IDA Ireland secured 246 new investments last year despite Covid-19
RTE
The number of jobs created at IDA Ireland-backed companies continued to grow last year, despite Covid-19.
In its annual statement the agency, which attracts foreign companies to locate in Ireland, said it had secured 246 new investments which created 20,123 new jobs.
Irish pharma group ICON plc carried out trial of Pfizer-BioNTech vaccine
The Irish Times
The trial, involving 44,000 participants, was largest trial of a Covid-19 vaccine
Irish clinical trials group Icon has revealed that it carried out the late-stage trial of the Pfizer-BioNTech coronavirus vaccine.
The trial, which involved 44,000 participants over a four-month period last year, was the largest trial of a Covid-19 vaccine.
Pfizer and BioNTech were the first to announce positive efficacy results from a late-stage study, and the first to receive authorisation for deployment.
Kerry distillery to invest €4m in business this year
The Irish Times
Skellig Six18 ramps up operations as it continues to raise funds for the business
Skellig Six18, which is developing a €10 million micro-distillery and visitor centre along the Ring of Kerry, is expecting to invest about €4 million in the business this year.
A Souderton firm played a key role in testing Pfizer’s COVID-19 vaccine
Philadelphia Inquirer
While the fanfare surrounding Pfizer’s recently approved COVID-19 vaccine resounds throughout pandemic-stricken America, a Souderton company that played a key role in its journey from test tube to approval is helping scores of other firms in their quests for successful encores.
Since early summer, Almac has been at the heart of the far-flung and intense search for drugs to combat the coronavirus, facilitating trials for the COVID-related products of at least 80 pharmaceutical and bio-tech companies, most notably the Pfizer vaccine that on Dec. 11 won emergency-use authorization from the U.S. Food and Drug Administration.
Tourism Ireland planning 2021 kick-start recovery campaign with ‘hope and optimism’
The Irish Examiner
